This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
F-18 fluoroestradiol (FES)-PETscans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. A visual abstract of the analysis.
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PETscans.
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PETscans per fixed PET site (versus mobile PET) increased 6.7%
Alzheimer’s disease patients with cognitive impairment or dementia who were referred for amyloid PETscans had fewer hospitalizations compared with a matched control group, according to a study published October 9 in JAMA Neurology. Each participant was matched to a control Medicare beneficiary who had not undergone amyloid PET.
The way physicians identify illness is changing due to advances in medical imaging, which make early diagnosis quicker, more precise, and less invasive. These technologies, ranging from high-resolution MRIs to state-of-the-art CT scans, can give doctors the ability to spot possible health problems before symptoms even show up.
Men should have prostate-specific membrane antigen (PSMA) PETscans about eight months after undergoing external beam radiotherapy for prostate cancer, a group at the University of California, Los Angeles has reported. The median duration between the first PETscan and the end-date of radiotherapy was 2.3
That’s according to new PETimaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.
F-18 florbetaben PETscans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PETimaging in clinical settings,” the group wrote.
The research included 62 cognitively healthy individuals (average age, 50) who underwent a brain PETscan, body MRI, and metabolic assessment. Images courtesy of the RSNA.
“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.
A PET study by researchers at the National Institutes of Health (NIH) has called into question the theory that ultraprocessed foods elicit brain responses akin to addictive drugs. Participants fasted for 12 hours before the first scan. Participants completed a five-day inpatient stay during which their diets were stabilized.
Food and Drug Administration (FDA) cleared deep-learning algorithm designed to enhance the efficiency and effectiveness of imaging procedures, Telix said. The algorithm allows for faster PETscanning, up to 75% faster without compromising image quality, according to the company.
TORONTO -- AuntMinnie.com spoke with prostate cancer imaging expert Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, at the Society of Nuclear Medicine and Molecular Imaging annual meeting about new developments in PET/CT imaging in patients on Lu-177 PSMA-617 therapy. last year for Alzheimer's disease.
An AI algorithm designed for brain PETimaging found a glioblastoma in a patient that had gone undetected by physicians, according to a case reported February 15 in the Journal of Nuclear Medicine. Baseline scan (A), segmentation results (B), and follow-up scan (C) from patient with molecular glioblastoma.
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
Florida resident Rick Nassenstein allegedly “played a central role” in a scheme that involved paying physicians “exorbitant” fees to refer patients for PETscans.
National Institutes of Health (NIH) has highlighted a study that shows cardiac PETscans can help identify people at risk for Parkinson’s disease and Lewy body dementia. Heart and brain PETscans from a study participant who developed Parkinson’s disease support a “body first” progression.
PETimaging shows different brain activity in people taking methadone or buprenorphine for opioid use disorder (OUD), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging annual meeting. Image and caption courtesy of Jacob Dubroff, MD, PhD.
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with high-efficacy disease-modifying therapies, according to a recent study by researchers in Boston. The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PETscans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PETscan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PETscans will now be made by local Medicare Administrative Contractors (MACs).
A group led by researchers at the University of Arizona has received a $4 million grant from the National Institutes of Health (NIH) to develop multitracer brain PETimaging technology. The group’s technology aims to overcome this limitation by taking advantage of prompt gamma signals in addition to the positron signals.
A group in England has established PETimaging as a new approach for studying gait – an excellent indicator of physical, emotional, and mental health, according to a study published February 6 in NeuroImage. F-18 FDG-PETscans allow clinicians to measure the brain's energy demands based on glucose metabolism.
PETScanning, like all other modalities of imaging equipment, has made strides in improving diagnostic accuracy. The biggest step in that direction for PET has been the development and proliferation of Time-of-Flight technology.
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PETimaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University. “In
Early brain accumulation of amyloid plaque on PETscans is associated with emerging depressive symptoms in cognitively unimpaired older adults, according to a study published August 29 in JAMA Network Open. The mean follow-up period was 8.6
Radiotracers are radioactive compounds which give off radiation that can be detected by scanners and turned into a 3D image. The new radiotracer, called FDT, enables PETscans to be used for the first time to accurately pinpoint when and where the disease is still active in a patient's lungs.
Gallium-68 (Ga-68) fibroblast activation protein inhibitor (FAPI) PET/CT is a promising new method for imaging gastric cancer, according to a study published January 16 in the Journal of Cancer Research and Clinical Oncology. indicating tracer accumulation on PET (arrowhead, d). The maximum projection image of PET (e).
Two experts review SNMMI (Society of Nuclear Medicine and Molecular Imaging) guidelines for use of PSMA PETscans in prostate cancer detection, as well as awareness about this new modality within the patient community.
Both amyloid plaque brain deposits and changes in cerebral blood flow (CBF) are key components of Alzheimer’s disease, with amyloid PETscans and MRI typically used separately to detect changes in these biomarkers in patients. Image courtesy of the Journal of Nuclear Medicine. A link to the full study is available here.
PETscans have revealed specific brain pathology that may drive sleep disturbances in Alzheimer’s disease patients, according to a study published February 8 in the Journal of the Neurological Sciences. Of these, 119 (43%) had normal cognition, 132 (24%) had mild cognitive impairment, and three (2%) had Alzheimer’s disease.
A deep-learning AI model shows promise in helping clinicians assess cardiac sarcoidosis on PETscans, according to research presented on September 6 at the American Society of Nuclear Cardiology annual meeting in Austin, TX. Image courtesy of the American Society of Nuclear Cardiology. mm versus 4.96
The team has worked for the past eight years on developing an approach of imaging cells called microglia. The team developed a technique called F18 PBR 06 PETimaging. The newly published study involved performing PETscans on 22 people with MS and eight healthy controls.
The accumulation of brain amyloid deposits is a mechanism underlying Alzheimers disease, with amyloid PETscans used to diagnose the disease. To address the knowledge gap, the group identified 182 out of 1,680 participants in an Alzheimers disease study in France and Monaco who had both PETscans and HSV-1 blood tests available.
FDG-PETimaging shows promise for use as a diagnostic criterion for neurosarcoidosis, with a recent case series illustrating the approach was effective when gold-standard approaches were not, according to a group of researchers in Berlin. “To In all three cases, gadolinium-enhanced MRI scans did not show abnormalities.
According to clinical trials, amyloid PETscans showed that donanemab reduced amyloid plaques by up to 84% after 18 months of treatment. Safety warnings include that the drug can cause amyloid-related imaging abnormalities, which are detected by MRI and present as temporary swelling in an area or areas of the brain.
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content